Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes

Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes

How are the cell counts and viabilities of BMMCs determined?

Cell counts and viability are determined using AOPI staining on a Nexcelom Cellometer.

Privacy Settings